Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Maturitas ; 178: 107827, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37659129

RESUMO

OBJECTIVES: Menopause presents various physical and psychological disturbances for women and comes at a high financial cost. Therefore, this study aimed to identify factors influencing menopause symptoms. STUDY DESIGN: Data of Korean perimenopausal women aged 40-60 (n = 1060; mean age, 46.03 ± 4.08) were collected by a research company. Participants were classified into a "functional" group (n = 716) or a "dysfunctional" group (n = 344) according to the severity of their perimenopausal psychosomatic symptoms. To investigate the association of obstetric and psychiatric history with membership of the "dysfunctional" group, a hierarchical logistic regression analysis was conducted. RESULTS: The outcomes of all three hierarchical logistic regression models presented significant overall model fit. Among the independent variables, family history of menopausal symptoms, menarcheal age, number of pregnancies, history of postpartum depression, postpartum psychosis, and other psychiatric disorders were positively associated with being in the "dysfunctional" group, whereas age and number of deliveries were negatively associated with being in the "dysfunctional" group. CONCLUSION: A short reproductive period and short exposure to estrogen due to late menarche and early menopausal transition may be related to severe perimenopausal symptoms. The relationship between the history of postpartum mental illness and severe perimenopausal symptoms may be associated with heightened sensitivity to hormonal triggers when a woman is exposed to fluctuating ovarian sex steroid levels. The relationship between parity or gravidity and the severity of menopausal symptoms in Korean women differed from that in studies conducted in other countries, possibly due to the low birth rate in Korea.


Assuntos
Transtornos Mentais , Perimenopausa , Gravidez , Feminino , Humanos , Perimenopausa/psicologia , Menopausa/psicologia , Transtornos Mentais/epidemiologia , Estrogênios , República da Coreia/epidemiologia
2.
Menopause ; 30(9): 961-968, 2023 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-37490658

RESUMO

OBJECTIVE: A detailed, well-validated scale for measuring emotional symptoms in menopausal women is lacking. We aimed to develop the Menopause Emotional Symptom Questionnaire (MESQ) and to confirm its reliability and validity among Koreans. METHODS: Eighteen primary items based on previous research results were selected using exploratory factor analysis and confirmatory factor analysis (CFA). New data, including answers to the novel MESQ, Menopause Rating Scale, Kupperman Index, Beck Depression Inventory-II, and Beck Anxiety Inventory, were collected from 200 perimenopausal women and 100 young men through a research company. Exploratory factor analysis and CFA were performed again to determine whether the MESQ accurately measures emotional symptoms in perimenopausal women. Receiver operating characteristic curve and k-means cluster analyses were used to identify the most appropriate cutoff value. RESULTS: The MESQ showed high internal consistency (Cronbach α = 0.926), and the CFA revealed that the factor structure comprised two subscales: nine items for mood/anxiety symptoms and four items for sleep symptoms. A high correlation between the total MESQ score and total scores of the existing scales was confirmed, indicating high convergence validity. Comparison of the mean MESQ scores between men and women showed significant sex difference, indicating secure known-group validity. The cutoff point of the total MESQ score between the high-risk and low-risk groups was 26. CONCLUSIONS: The novel MESQ has high validity and reliability, and this study confirmed that the MESQ is a valid tool for screening for and measuring emotional symptoms in menopausal women in Korea.


Assuntos
Emoções , Menopausa , Humanos , Feminino , Masculino , Reprodutibilidade dos Testes , Psicometria , Menopausa/psicologia , Inquéritos e Questionários
3.
J Acad Consult Liaison Psychiatry ; 64(2): 136-146, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36031073

RESUMO

BACKGROUND: Over 80% of perimenopausal women experience various physical and neuropsychiatric symptoms due to changes in hormones. However, accurate evaluation and treatment of menopausal symptoms are lacking due to limited evidence regarding customized treatment for each symptom type. OBJECTIVE: This study aimed to identify and cluster psychosomatic symptoms in Korean perimenopausal women and to investigate the characteristics of each cluster type. METHODS: This Web-based survey assessed 1060 Korean perimenopausal women recruited from nationally representative panels available from a commercial research company. Menopausal symptoms were evaluated using the Menopause Rating Scale, Patient Health Questionnaire-15, Patient Health Questionnaire-9, Insomnia Severity Index, Subjective Memory Complaints Questionnaire, and Overactive Bladder Symptom Score. Data were analyzed using latent profile analysis and multinomial logistic regression. RESULTS: Latent profile analysis identified 4 latent classes: "all unimpaired (class 1)," "impaired sexual function, while others are unimpaired (class 2)," "unimpaired sexual function, while others are impaired (class 3)," and "all impaired (class 4)." Classes 3 and 4 were significantly more likely to have a family history of perimenopausal syndrome and a history of other mental disorders, postpartum depression, and postpartum psychosis than classes 1 and 2. CONCLUSIONS: Psychosomatic symptoms appear during perimenopause along with depression, somatic symptoms, insomnia, impaired memory, and overactive bladder symptoms. Individuals with these symptoms are more likely to have a history of postpartum depression, psychosis, and other psychiatric disorders. Therefore, sexual dysfunction must be independently treated. Further studies are needed to develop and verify individualized treatments according to symptom class.


Assuntos
Depressão Pós-Parto , Disfunções Sexuais Fisiológicas , Distúrbios do Início e da Manutenção do Sono , Bexiga Urinária Hiperativa , Feminino , Humanos , Perimenopausa/psicologia , Menopausa/psicologia , Transtornos Psicofisiológicos/epidemiologia
4.
PLoS One ; 16(7): e0254357, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34252091

RESUMO

Olfactory impairment is associated with dementia and is a potential early biomarker of cognitive decline. We developed a novel olfactory threshold test called Sniff Bubble using rose odor-containing beads made with 2-phenylethyl alcohol. We aimed to define cut-off scores for this tool to help identify cognitive decline among elderly people. In total, 162 elderly people (mean age ± SD: 73.04 ± 8.73 years) were administered olfactory threshold and neurocognitive tests. For analyses, we divided the participants into two groups based on cognitive functioning, namely cognitive decline (n = 44) and normal cognition (n = 118) groups. The Sniff Bubble and YSK olfactory function test for olfactory threshold and the Structured Clinical Interview for DSM-5 Disorders-Clinician Version and Korean version of the Consortium to Establish a Registry for Alzheimer's Disease assessment packet for neurocognitive functioning were used. We used K-means cluster analyses and receiver operating characteristic (ROC) analyses to identify the most appropriate cut-off value. We established a positive correlation between the Sniff Bubble and neurocognitive function test scores (r = 0.431, p < 0.001). We defined the cut-off score, using the ROC curve analyses for Sniff Bubble scores, at 3 and higher with an area under the curve of 0.759 (p < 0.001). The Sniff Bubble test can adequately detect cognitive decline in elderly people and may be used clinically as the first step in the screening process.


Assuntos
Disfunção Cognitiva/fisiopatologia , Programas de Rastreamento , Limiar Sensorial/fisiologia , Olfato/fisiologia , Idoso , Idoso de 80 Anos ou mais , Área Sob a Curva , Análise por Conglomerados , Feminino , Humanos , Masculino , Testes de Estado Mental e Demência , Pessoa de Meia-Idade , Curva ROC
5.
Clin Psychopharmacol Neurosci ; 19(2): 361-366, 2021 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-33888665

RESUMO

OBJECTIVE: In somatic symptom disorder (SSD), cognitive dysfunction is related to perceptive distortion that excessively amplifies bodily sensations. The association between high body mass index (BMI) and cognitive dysfunction could be attributed to underlying systemic inflammation. We aimed to evaluate whether patients with SSD and high BMI exhibit increased somatic symptom severity and whether this is mediated by cognitive dysfunction. METHODS: This retrospective, cross-sectional study was conducted on 54 patients with SSD (20 males/34 females, mean age ± standard deviation: 40.65 ± 13.23 years). Participants' BMI, laboratory data including complete blood count and lipid profile, results from the Korean Wechsler Adult Intelligence Scale-IV, and scores of the Korean-Symptom Checklist 95-Somatization (SCL95-SOM) were analyzed. We performed a path analysis to evaluate BMI as a predictor of somatic symptoms. RESULTS: In a path analysis, the SCL95-SOM score was directly influenced by working memory (b = -0.326, p = 0.032), which was significantly influenced by BMI (b = -0.338, p = 0.009), although there was no direct effect of BMI on the SCL95-SOM score. The path analytic model showed a close fit to the data with the following values: χ2 (df) = 0.918 (1), p = 0.338, root mean square error of approximation = 0.000 (< 0.001), and comparative fit index = 1.00. CONCLUSION: Patients with SSD and high BMI may exhibit increased somatic symptom severity, and this is mediated by working memory dysfunction. Weight management may help improve symptoms in patients with SSD and high BMI.

6.
Psychiatry Investig ; 17(2): 106-113, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32024354

RESUMO

OBJECTIVE: Our previous study suggested that monitoring online board gamers may be an efficient approach to curb illegal gambling. We aimed to invent and validate a behavioral scale for assessing the risk of problematic web-based board gaming. METHODS: The sample included 300 Korean adults, representing a response rate of 3.1%. All participants were asked to complete a set of questionnaires, which included questions on demographic variables, patterns of online board gaming, and the web-based board game scale score. Exploratory factor analysis was performed to determine whether the items on the new behavioral scale would indicate a risk of pathologic web-based board gaming behavior. RESULTS: The internal consistency of the 17-item scale was high (Cronbach's α=0.89). The test-retest reliability of the 17-item scale in a randomly selected sample of 100 participants in 2 weeks was r=0.77 (p<0.001). The criterion-related validity based on a comparison of the total behavioral scale scores between the high-risk group and low-risk group was relatively high. The data obtained from the 300 participants were acceptable for a factor analysis. After removing 7 items from the 17-item scale, internal consistency (Cronbach's α) of the 10-item scale increased to 0.936. CONCLUSION: These results showed that the 10-item version of the scale appeared to be more valid than the 17-item version. We suggest that the 10-item web-based board game behavioral scale is a useful tool for assessing the risk of pathologic web-based board gaming.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...